Iteos Therapeutics Inc (ITOS)

Stock price, financials, and technical signals for Iteos Therapeutics Inc (ITOS).

$7.29

0.11

(1.53%)

As of 02/12/2025 5:00 PM ETDisclaimer
Powered by Stocksift.com

100%

ITOS Performance Snapshot


1-Week Chg

-6.78%

1-Month Chg

-6.06%

3-Month Chg

-20.67%

6-Month Chg

-49.72%

1-Year Chg

-32.81%

Year-To-Date Chg

-7.72%

Beta 1-Year

2.19

Beta 5-Year

1.36

Volatility (10-Day)

2.95%

ITOS Technicals



Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-02-12

$7.29

$0.11 (1.53%)

$7.12

$7.31

$7.06

$7.22

146.15K ($1.07M)

2025-02-11

$7.18

$0 (0%)

$7.18

$7.25

$7.08

$7.17

353.18K ($2.54M)

2025-02-10

$7.18

-$0.41 (-5.4%)

$7.54

$7.58

$7.10

$7.29

395.86K ($2.84M)

2025-02-07

$7.59

-$0.19 (-2.44%)

$7.77

$7.85

$7.49

$7.64

169.62K ($1.29M)

2025-02-06

$7.78

-$0.04 (-0.51%)

$7.84

$7.88

$7.73

$7.80

139.28K ($1.08M)

2025-02-05

$7.82

$0.34 (4.55%)

$7.50

$7.93

$7.40

$7.72

274.52K ($2.15M)

2025-02-04

$7.48

$0.11 (1.49%)

$7.40

$7.58

$7.37

$7.48

174.74K ($1.31M)

2025-02-03

$7.37

-$0.17 (-2.25%)

$7.41

$7.52

$7.30

$7.40

194.09K ($1.43M)

2025-01-31

$7.54

-$0.14 (-1.82%)

$7.73

$7.85

$7.49

$7.63

232.42K ($1.75M)

2025-01-30

$7.68

$0.19 (2.54%)

$7.49

$7.91

$7.41

$7.67

227.46K ($1.75M)

ITOS Financials


Balance Sheet

(USD)

2024 Q3

Y/Y CHANGE


  • Cash and equivalents

    $124.05M

    -39.31%

  • Total assets

    $723.08M

    6.70%

  • Total liabilities

    $91.39M

    15.12%

  • Total investments

    $525.16M

    19.14%

  • Shareholders' equity

    $631.69M

    5.59%

  • Book value per share

    $14.64

    -12.41%


Income Statement

(USD)

2024 Q3

Y/Y CHANGE


  • Revenue

    $0

    0%

  • Net income

    -$45.36M

    -40.68%

  • Operating expense

    $48.80M

    12.75%

  • Gross profit

    $0

    0%

  • EBITDA

    -$42.81M

    -28.96%

  • Earnings per share

    -$1.05

    -16.67%


Cash Flow

(USD)

2024 Q3

Y/Y CHANGE


  • Net change in cash

    -$127.35M

    -954.03%

  • Cash from operations

    -$37.35M

    -10.21%

  • Cash from investing

    -$91.49M

    -503.16%

  • Cash from financing

    -$442.00K

    -4520.00%

  • Free cash flow

    -$37.45M

    -8.09%

  • Free cash flow per share

    -$0.87

    10.33%


Metrics

(USD)

2024 Q3

Y/Y CHANGE


  • Market capitalization

    $372.89M

    -4.83%

  • Enterprise value

    $127.00M

    -29.75%

  • Shares outstanding

    36.52M

    2.07%

  • Profit margin

    -

    -

  • Gross margin

    -

    -

  • EBITDA margin

    -

    -


Dividends

(USD)

2024 Q3

Y/Y CHANGE


  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    14.80

    -32.53%


Stocksift logo icon

Stocksift Uses Cookies

We use cookies to improve and customize your experience on our site. By using our site, you agree to our use of cookies.